Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) EPS (Basic): 2019-2024

Historic EPS (Basic) for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to -$10.21.

  • Praxis Precision Medicines' EPS (Basic) fell 22.18% to -$3.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.96, marking a year-over-year decrease of 39.50%. This contributed to the annual value of -$10.21 for FY2024, which is 45.37% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported EPS (Basic) of -$10.21 as of FY2024, which was up 45.37% from -$18.69 recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' EPS (Basic) peaked at -$3.94 during FY2021, and registered a low of -$69.65 during FY2022.
  • Moreover, its 3-year median value for EPS (Basic) was -$18.69 (2023), whereas its average is -$32.85.
  • In the last 5 years, Praxis Precision Medicines' EPS (Basic) plummeted by 1,667.77% in 2022 and then skyrocketed by 73.17% in 2023.
  • Yearly analysis of 5 years shows Praxis Precision Medicines' EPS (Basic) stood at -$7.86 in 2020, then skyrocketed by 49.87% to -$3.94 in 2021, then tumbled by 1,667.77% to -$69.65 in 2022, then spiked by 73.17% to -$18.69 in 2023, then surged by 45.37% to -$10.21 in 2024.